Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Apr 25, 2026 | Business
Unveiling new targets in LAR triple-negative breast cancer: ERBB2 mutations and senescence
Apr 25, 2026 | Business
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries.
Apr 25, 2026 | Lifestyle
A new collection explores champagne tones through antique cuts, shaped in Elora's own cutting atelier.